ALPS Medical Breakthroughs ETF (SBIO)

$30.6573

+1.46 (+5.00%)
Rating:
Recommendation:
-
Symbol SBIO
Price $30.6573
Beta 0.000
Volume Avg. 0.02M
Market Cap 9.246B
Shares () -
52 Week Range 23.58-49.64
1y Target Est -
DCF Unlevered SBIO DCF ->
DCF Levered SBIO LDCF ->
ROE -
ROA -
Operating Margin -
Debt / Equity -
P/E -
P/B -
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest SBIO news


None
New York Stock Exchange Arca

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.